Thought it would be good to discuss what happens after the MDA is awarded and what milestones/triggers will then see the share price further re-rate. A couple of extracts from the half yearly report to prompt that discussion;
- Will the placement funds be enough to take us through from MDA approval to the CR for funding the Phase 1 Pilot?
- The MDA will no doubt re-rate the share price but to what extent?
- What other news between MDA signing and the Phase 1 Pilot CR will help to hold/lift that share price and bolster the CR?
- How much will it cost to build the Phase 1 Pilot plant and refinery? (estimate due Oct 2023)
- No revenue from the Phase 1 Pilot until Q3/2024 so 18 months of funding needed until we are generating cash
- The revenue from the Pilot at 90,000 tpa rather than 1,500,000 tpa for Phase 2 are not going to be significant (just 6% the size)
- What is the timeframe to go from Phase 1 Pilot to Phase 2 Production - that's where the real profits will lie
- Forums
- ASX - By Stock
- GBE
- After the MDA
After the MDA
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GBE (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
0.001(1.92%) |
Mkt cap ! $35.82M |
Open | High | Low | Value | Volume |
5.5¢ | 6.0¢ | 5.1¢ | $67.47K | 1.222M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 119563 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 105000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 119563 | 0.053 |
1 | 150000 | 0.052 |
1 | 11951 | 0.050 |
1 | 100000 | 0.042 |
3 | 400000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 105000 | 2 |
0.058 | 20000 | 1 |
0.061 | 66409 | 2 |
0.062 | 204817 | 1 |
0.120 | 60000 | 1 |
Last trade - 15.39pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
5.5¢ |
  |
Change
0.001 ( 10.0 %) |
|||
Open | High | Low | Volume | ||
5.5¢ | 5.6¢ | 5.5¢ | 86173 | ||
Last updated 14.57pm 06/05/2024 ? |
Featured News
GBE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online